Option Care Health Inc. (OPCH)
undefined
undefined%
At close: undefined
23.49
-0.06%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Option Care Health, Inc. offers home and alternate site infusion services in the United States.

The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services.

Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Option Care Health Inc.
Option Care Health Inc. logo
Country United States
IPO Date Aug 15, 1996
Industry Medical - Care Facilities
Sector Healthcare
Employees 7,500
CEO John C. Rademacher

Contact Details

Address:
3000 Lakeside Drive
Bannockburn, Illinois
United States
Website https://www.optioncarehealth.com

Stock Details

Ticker Symbol OPCH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001014739
CUSIP Number 68404L201
ISIN Number US68404L2016
Employer ID 05-0489664
SIC Code 8082

Key Executives

Name Position
John C. Rademacher Chief Executive Officer, President & Director
Brett Michalak Chief Information Officer
Luke Whitworth Chief Operating Officer
Michael H. Shapiro Executive Vice President & Chief Financial Officer
Caroline Budde Senior Vice President & Chief Compliance Officer
Chris Grashoff Chief Growth Officer
Collin G. Smyser General Counsel & Corporate Secretary
Julie Koenig Senior Vice President of Operations
Michael Bavaro Chief Human Resources & Chief Diversity Officer
Nicole Maggio Principal Accounting Officer

Latest SEC Filings

Date Type Title
Dec 04, 2024 SCHEDULE 13G/A [Amend] Filing
Nov 13, 2024 4 Filing
Nov 08, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Oct 29, 2024 4 Filing
Oct 23, 2024 4 Filing
Oct 23, 2024 4 Filing
Oct 23, 2024 4 Filing
Oct 23, 2024 4 Filing